Canada Spends Logo

Explore our Budget 2026 analysis

Grant: CIHR Fellowship

McMaster University

$135,000.00

Using Behavioural Economics to Understand Concurrent Substance Use Disorders and Post-Traumatic Stress Disorder

FY 2021-22

Summary
Substance use disorders (SUDs) remain the most common psychiatric conditions in Canada. Often, however, SUDs do not exist in isolation, but are concurrent with comorbid mental illness. One such common comorbidity is with post-traumatic stress disorder (PTSD). This high co-prevalence is concerning, as individuals with SUD+PTSD show less improvement and earlier drop out from treatment, higher rates of relapse, and higher rates of suicide. Comorbid SUD+PTSD is substantially less well understood than either disorder individually, but its etiology may be elucidated using behavioural economics. From a behavioural economic perspective, SUDs are a product of three core processes: 1) overvaluation of smaller immediate rewards over larger future ones ("delay discounting"); 2) overvaluation of drug reinforcement ("drug demand"); and 3) low availability of substance-free reinforcement ("alternative reinforcement"). This is the reinforcer pathology (RP) model of addiction, which has been well supported for various types of SUDs, including alcohol, cannabis, cocaine, and opioids. Here, I propose an extension of the RP model to explain comorbid SUD+PTSD, with further elevations expected on the three core behavioural economic indicators due to substantial negative reinforcement (distress relief) drug motivation. The RP model will be applied to five diverse samples, with the aims to 1) predict problematic substance use and SUDs among those with concurrent PTSD or PTSD symptomology; 2) differentiate non-clinical and clinical samples; and 3) determine directional associations between PTSD and SUD from longitudinal data. The results will substantially extend our knowledge of this common and clinically challenging comorbidity, with promise for informing existing treatments and developing novel interventions.
Program
CIHR Fellowship
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
454948
Name
Bird Brian
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Neurosciences, Mental Health and Addiction
Theme2
Clinical
Prcname2
Health Research Training A - Post-PhD (HTA)
Projecttitle
Using Behavioural Economics to Understand Concurrent Substance Use Disorders and Post-Traumatic Stress Disorder
Programtype2
Fellowship Programs
Orgnameinp2
McMaster University
Cihramount2
$135,000
Cihrequipment2
$0
Programname2
CIHR Fellowship
Keyworddelim
Addiction; Behavioral Economics; Concurrent Disorders; Delay Discounting; Post Traumatic Stress Disorder; Reinforcer Pathology Model; Substance Use Disorder
Abstract
Substance use disorders (SUDs) remain the most common psychiatric conditions in Canada. Often, however, SUDs do not exist in isolation, but are concurrent with comorbid mental illness. One such common comorbidity is with post-traumatic stress disorder (PTSD). This high co-prevalence is concerning, as individuals with SUD+PTSD show less improvement and earlier drop out from treatment, higher rates of relapse, and higher rates of suicide. Comorbid SUD+PTSD is substantially less well understood than either disorder individually, but its etiology may be elucidated using behavioural economics. From a behavioural economic perspective, SUDs are a product of three core processes: 1) overvaluation of smaller immediate rewards over larger future ones ("delay discounting"); 2) overvaluation of drug reinforcement ("drug demand"); and 3) low availability of substance-free reinforcement ("alternative reinforcement"). This is the reinforcer pathology (RP) model of addiction, which has been well supported for various types of SUDs, including alcohol, cannabis, cocaine, and opioids. Here, I propose an extension of the RP model to explain comorbid SUD+PTSD, with further elevations expected on the three core behavioural economic indicators due to substantial negative reinforcement (distress relief) drug motivation. The RP model will be applied to five diverse samples, with the aims to 1) predict problematic substance use and SUDs among those with concurrent PTSD or PTSD symptomology; 2) differentiate non-clinical and clinical samples; and 3) determine directional associations between PTSD and SUD from longitudinal data. The results will substantially extend our knowledge of this common and clinically challenging comorbidity, with promise for informing existing treatments and developing novel interventions.
Competitiondate
202110
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Bird, Brian
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $135,000~ $0~